Condition category
Signs and Symptoms
Date applied
30/09/2005
Date assigned
30/09/2005
Last edited
07/04/2011
Prospective/Retrospective
Retrospectively registered
Overall trial status
Stopped
Recruitment status
Stopped

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr Iain Murray

ORCID ID

Contact details

Royal Cornwall Hospitals NHS Trust
Treliske
Truro
TR1 3LJ
United Kingdom
+44
Iain.Murray@rcht.cornwall.nhs.uk

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N0202140085

Study information

Scientific title

Acronym

Study hypothesis

How many patients develop MRSA infection to their gastrostomy site using our present antibiotic prophylaxis and whether infection can be prevented by the use of intravenous teicoplanin or by inserting the gastrostomy tube radiologically rather than endoscopically?

Ethics approval

Not provided at time of registration

Study design

Prospective randomised pilot study

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Hospitals

Trial type

Treatment

Patient information sheet

Condition

Signs and Symptoms: MRSA peristomal infections

Intervention

Use of intravenous teicoplanin or inserting the gastrostomy tube radiologically rather than endoscopically.

Added May 2008: Randomised:
1. RIG + cefotaxime
2. PEG + cefotaxime
3. PEG + teicoplanin

Intervention type

Drug

Phase

Not Specified

Drug names

teicoplanin

Primary outcome measures

Not provided at time of registration

Secondary outcome measures

Not provided at time of registration

Overall trial start date

01/06/2004

Overall trial end date

31/12/2006

Reason abandoned

Interim results no reduction in MRSA infection rate provided either by use of teicoplanin or with the tube being inserted radiologically rather than endoscopically.

Eligibility

Participant inclusion criteria

Added May 2008:
1. Subjects over 16 years
2. Referred for PEG/RIG
3. Informed written consent

Participant type

Patient

Age group

Not Specified

Gender

Not Specified

Target number of participants

Planned 240

Participant exclusion criteria

Added May 2008:
1. Oropharyngeal cancer
2. Already taking antibiotics

Recruitment start date

01/06/2004

Recruitment end date

31/12/2006

Locations

Countries of recruitment

United Kingdom

Trial participating centre

Royal Cornwall Hospitals NHS Trust
Truro
TR1 3LJ
United Kingdom

Sponsor information

Organisation

Department of Health

Sponsor details

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
+44 (0)20 7307 2622
dhmail@doh.gsi.org.uk

Sponsor type

Government

Website

http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Funder name

Royal Cornwall Hospitals NHS Trust (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes